Dr. Lichaa details his presentation from TCT 2023, which covers tips and tricks for dealing with peripheral challenges. In low-risk patients with symptomatic AS, TAVR is safe, effective, and durable up to 5 years. Dr. Nabil Dib discusses his UltraNav Transseptal Catheter System. Patients with severe aortic stenosis who have low surgical risk have better outcomes using TAVR compared with SAVR. Researchers analyzed the long-term impact of TAVR on coronary arteries and cardiac hemodynamics. A combination therapy of a statin and ezetimibe significantly reduces cardiovascular events in patients undergoing PCI.